Back to Agenda
International Regulation and Harmonisation: A Global Approach
Session Chair(s)
Virginia Acha
AVP, Science and Regulatory Policy, Merck & Co., Inc., United Kingdom
Despite over five decades in development and use, regulation for drug-device combination faces challenges in international alignment and keeping pace with technology. In this session, we will explore the current global landscape and prospects for alignment.
Learning Objective : - Outline of Reg landscape for combination products in international markets - Assessment of available pathways in various markets - What does it take for a global submission? - Case study- global submission of a combination product
Speaker(s)
Scene Setter: Combination Products – A Global Policy Landscape
Pieter Stolk
Co-Founder & Partner, Exon Consultancy, Netherlands
Navigating Global Regulatory Policy Differences for Combination Products – Pharma View
Shruthi Vidyasagar, MS
Associate Director, Novo Nordisk, India
Opportunities for Alignment – Regulator's Perspective
Alberto Ganan Jimenez, PhD
Head of Committees and Quality Assurance, European Medicines Agency, Netherlands
Panelist
Susanna Palkonen
Director, EFA (European Federation of Allergy and Airways Diseases Patients' Associations), Belgium
Have an account?